Treatment consists of Anti-VEGF drugs like Lucentis or intravitreal steroid implant (Ozurdex) and Pan-Retinal Laser Photocoagulation usually. Underlying conditions also require treatment.<unk>  without ischemia has better visual prognosis than ischemic<unk> . A systematic review studied the effectiveness of the anti-VEGF drugs ranibizumab and pagatanib sodium for patients suffering from non-ischemic<unk> . Though there was a limited sample size, participants in both treatment groups showed improved visual acuity over 6 month periods, with no safety concerns.
Central retinal vein occlusion
Branch retinal vein occlusion
Branch retinal artery occlusion
Retinal vasculitis
Central retinal artery occlusion
Arteritic anterior ischemic optic neuropathy
Posterior ischemic optic neuropathy
Ischemic optic neuropathy